Table 4.

An overview of the literature pertaining to the remission of gastroesophageal reflux symptoms and the use of acid suppression medications pre- and post-sleeve gastrectomy. ACM = acid suppression medication, GERD = gastroesophageal reflux disease, (L)SG = (laparoscopic) sleeve gastrecromy, N/R = not reported.

Exacerbation or Remission of Gastroesophageal Reflux Symptoms and the Use of Acid Suppression Medications Pre- and Post-Sleeve Gastrectomy
Author	Year	Journal	Article Type	Number of Cases/Studies	GERD Symptom Remission	Pre- and Post-SG Usage of Acid Suppression Medications	Additional Comments
Carter et al. [17]	2011	Surgery for Obesity and Related Diseases	Retrospective review	176	Pre-SG, 34.6% had GERD symptoms Post-SG, 49% reported GERD symptoms within 30 days 47.2% had persistent GERD (>1 month after LSG)	Pre-LSG: 22% → Post-LSG 33.8% of patients on GERD medication, p = 0.0428
Tai et al. [13]	2013	Surgical Endoscopy	Retrospective review	66	Prevalence of GERD symptoms pre-LSG 12.1% → 47% post-LSG, p < 0.001	N/R	New-onset GERD after LSG: 44.8% Hiatal hernia: 6.1% → 27.3%
Howard et al. [14]	2011	Surgery for Obesity and Related Diseases	Retrospective review	28	25% pre-LSG → 23% post-LSG, p < 0.05	Pre-LSG: 25% → post-LSG 39% with GERD symptoms despite ACM use	New-onset GERD post-LSG: 22%